Cannabis Law Report

SEPTEMBER 23, 2022

SB 57 – which passed both houses – would have created a pilot program for overdose prevention sites in San Francisco, Oakland, and Los Angeles as an evidence-based intervention to curb drug overdose deaths. The continued criminalization of all drugs and the people who use them increases harms to public health and safety. ABOUT MAPS.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

MMJ Recs

DECEMBER 13, 2023

Legal Framework: Texas Compassionate Use Program Texas has historically maintained strict laws against the use of marijuana for both medicinal and recreational purposes. While this was a positive development, the scope remained limited compared to other states with more comprehensive MMJ programs.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

The Blunt Truth

JULY 5, 2023

Starting August 1, 2023, Minnesota will provide protections to individuals who use cannabis for recreational purposes, after Minnesota Governor Tim Walz signed a state law allowing adults 21 and older to use recreational cannabis. What about random, reasonable suspicion, post-accident, and treatment program testing for cannabis?

Law 52

Law Recreational Policy Treatment 52

MMJ Recs

JANUARY 20, 2024

Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

The Blunt Truth

AUGUST 22, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or.

Safety 111

Safety Environment Policy Recreational 111

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

JULY 21, 2022

Although currently unfunded, the Cannabis Employment Protections Amendment Act of 2022 will prohibit employers from taking adverse action against employees or applicants based on their use of cannabis, their status as a medical cannabis program patient, or their failed marijuana drug test without additional indicia of impairment.

Recreational 52

Recreational Safety Programs Patients 52

Medicinal Genomics

JULY 18, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Those with compromised immune systems, either through disease or medical treatment, are at serious risk of developing an aspergillosis infection. What is Aspergillus ? link] A.

Medicine 81

Medicine Patients Cannabis Therapy 81

Cannabis Law Report

AUGUST 23, 2022

Employers can maintain a reasonable drug-free workplace policy that: Requires post-accident or reasonable suspicion drug testing of all employees or random drug testing of safety-sensitive workers; Is necessary to comply with federal law or a federal contract or funding agreement, if applicable to the employer; or.

Safety 52

Safety Environment Policy Recreational 52

Cannabis Law Report

NOVEMBER 4, 2021

The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. Measure 109 requires the Advisory Board to give recommendations to OHA on the efficacy and safety of psilocybin therapy. By Brett Mulligan.

Law 52

Law Therapy Treatment Policy 52

Medicinal Genomics

AUGUST 8, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Those with compromised immune systems, either through disease or medical treatment, are at serious risk of developing an aspergillosis infection. What is Aspergillus ? link] A.

Medicine 52

Medicine Patients Cannabis Therapy 52

Medicinal Genomics

JULY 18, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Those with compromised immune systems, either through disease or medical treatment, are at serious risk of developing an aspergillosis infection. What is Aspergillus ? link] A.

Medicine 52

Medicine Patients Cannabis Therapy 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 9] Experts predict that this therapy could receive full FDA approval as soon as 2023. [10] Defining Psychedelics. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JANUARY 9, 2022

Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. Colorado has a robust medical program, with about 1.6% Legalizing cannabis for adults has been a wise investment. of the population enrolled.

Collective 52

Collective Policy Retail Programs 52

Cannabis Law Report

SEPTEMBER 10, 2022

The Oregon legislative Task Force on Cannabis-Derived Intoxicants and Illegal Cannabis Production is exploring potential reforms to the state’s regulation of cannabinoid products and legislation for 2023 to combat what law enforcement believes is an increase in illicit marijuana production. The OLCC argued that H.B.

Seed-To-Sale 52

Seed-To-Sale Hemp Cannabinoids Legislation 52

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Objectives for FY 2023 also remain unchanged and do not include any COVID-19 impact either.

Business 105

Business Research and Development Environment Food 105

Veriheal

SEPTEMBER 7, 2022

implemented a revolutionary emergency amendment to its medical cannabis program. ’s Medical Cannabis Program. law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. ’s medical program to its limits is viewed as a stopgap until federal reform enables D.C.

Patients 97

Patients Programs Access Treatment 97

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Veriheal

DECEMBER 22, 2022

“Kentuckians suffering from chronic and terminal conditions are going to be able to get the treatment they need without living in fear of a misdemeanor,” Beshear said at the press conference, where two leading cabinet officials accompanied him. “Right now, there are no checks on how it’s packaged or sold.

THC 62

THC Conditions Policy Packaging 62